Simplifying Global Compliance
FDAnews Device Daily Bulletin
BOSTON SCIENTIFIC ANNOUNCES PRICING OF $750 MILLION OF SENIOR NOTES
Nov. 16, 2005
Boston Scientific recently announced the pricing of a public offering of $750
million aggregate principal amount of its senior notes under the Company's existing
shelf-registration statement. The public offering consists of $400 million of
5.50 percent notes due November 15, 2015 and $350 million of 6.25 percent notes
due November 15, 2035.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing